Features of patients with inflammatory bowel diseases who develop hemophagocytic lymphohistiocytosis

Saved in:
Bibliographic Details
Published inInternational journal of colorectal disease Vol. 31; no. 7; pp. 1375 - 1376
Main Authors Li, Y., Li, C. F., Zhang, J., Xia, X. F., Zhou, L. Y., Liu, J. J., Song, Z. Q., Lv, Y. M., Wang, A. Y., Zhang, Y. P., Liang, C. F., Shi, Y. Y., Quigley, E. M., Huang, Y. H., Ding, S. G.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.07.2016
Springer
Springer Nature B.V
Subjects
Adult
Case-Control Studies
Female
Gastroenterology
Gastrointestinal diseases
Hepatology
Humans
Immunosuppression
Inflammatory Bowel Diseases - complications
Inflammatory Bowel Diseases - drug therapy
Internal Medicine
Letter to the Editor
Lymphohistiocytosis, Hemophagocytic - complications
Lymphohistiocytosis, Hemophagocytic - drug therapy
Lymphohistiocytosis, Hemophagocytic - virology
Male
Medicine
Medicine & Public Health
Proctology
Purines - therapeutic use
Remission Induction
Surgery
Inflammatory Bowel Disease
Infliximab
Acute Pancreatitis
Immunosuppressive Regimen
Inflammatory Bowel Disease Patient
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:0179-1958
1432-1262
DOI:10.1007/s00384-015-2485-2